Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Cyclopentolate HCI I.P. 1% w/v , Chlorbutol I.P. 0.5% w/v Eye Drop
Therapeutic Category
Ophthalmology
Dosage Form
Eye Drops
Packaging Type
Dropper
Packaging
5ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Cyclin Eye Drop (Cyclopentolate HCl 1% + Chlorbutol) is a high-profit, essential clinical product built for our PCD Pharma Franchise partners.
This eye drop is mandatory for routine and specialized eye examinations, serving as a powerful mydriatic (pupil dilation) and cycloplegic (temporary paralysis of the focusing muscle). Its frequent use in ophthalmic clinics, hospitals, and diagnostic labs guarantees stable, consistent demand.
Why Cyclin is Your Key to Profit:
Essential Clinical Demand: Cyclopentolate is a non-negotiable tool for fundus examination and treating certain eye inflammations. This ensures consistent, recurring institutional revenue not tied to patient illness cycles.
Excellent Niche Margin: Positioned as an essential item in the specialty ophthalmic segment, this product commands superior pricing and secures some of the highest profit margins within its clinical niche.
Clinic Loyalty: The proven efficacy and quick action of this formulation build strong prescription and procurement loyalty from ophthalmologists and their clinics.
Monopoly Opportunity: We offer exclusive rights for your area—meaning zero competition in your designated specialty clinics and diagnostic centers. Partner with us for full marketing support to capture the steady, high-value demand.
Contact us today to secure this high-margin diagnostic segment!
The eye drop is generally well-tolerated. Mild side effects may include temporary stinging, burning, or slight redness upon application. Rarely, allergic reactions such as itching, swelling, or increased irritation may occur. Discontinue use and consult a healthcare professional if severe reactions develop.
Lubicom Ultra Eye Drop is indicated for relief from dry eyes, irritation, and oxidative stress-related ocular discomfort. It helps in lubricating the eyes, protecting against free radical damage, and improving overall eye health. It may also support visual clarity and reduce age-related oxidative changes in the eyes.
Use Lubicom Ultra Eye Drop exactly as directed. Avoid touching the dropper tip to the eye or any surface to prevent contamination. Remove contact lenses before application and wait at least 15 minutes before reinserting them. This product is for ocular use only and should not be swallowed.
Store Lubicom Ultra Eye Drop in a cool, dry place below 25°C, protected from direct sunlight. Keep the bottle tightly closed when not in use and out of reach of children. Discard any unused solution after the expiry date.
Composition : Torsemide 10mg Tablet
Composition : Torsemide 100mg Tablet
Composition : Torsemide 20 mg Tablet
Composition : Torsemide 40mg Tablet
Composition : Torsemide 5mg Tablet
Composition : Torsemide (10mg/ml) Injection
Composition : Torsemide 5 mg + Spironolactone 50 mg Tablet
Composition : TORSEMIDE 10 MG + SPIRONOLACTONE 25 MG
Composition : Torsemide 10mg + Spironolactone 50mg Tablets
Composition : Chlorthalidone 6.25mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This ophthalmic formulation has strong demand in the eye care and ophthalmology segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in eye examinations (pupil dilation), uveitis management, and diagnostic ophthalmic procedures. It strengthens their ophthalmic and eye care portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Cyclopentolate HCl I.P. 1% w/v + Chlorbutol Eye Drops with monopoly rights, promotional support, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady demand in eye clinics and hospitals, good margins, and consistent prescription-based usage when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this ophthalmic formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk orders, pricing details, and distribution support services.